Mulberrofuran G

Catalog No. :
ACAVOQ618
CAS No. :
87085-00-5
Molecular Formula :
C34H26O8
Molecular Weight :
562.57

IUPAC Name:8a-(2,4-dihydroxyphenyl)-6-(6-hydroxybenzofuran-2-yl)-2-methyl-1,3a1,8a,13b-tetrahydro-3aH-benzo[3,4]isochromeno[1,8-bc]chromene-4,11-diol

Mulberrofuran G structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$309.00Login to see priceInquiryInquiry
5mg98%$715.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMulberrofuran G
IUPAC Name8a-(2,4-dihydroxyphenyl)-6-(6-hydroxybenzofuran-2-yl)-2-methyl-1,3a1,8a,13b-tetrahydro-3aH-benzo[3,4]isochromeno[1,8-bc]chromene-4,11-diol
MDL No.MFCD31631870
Molecular FormulaC34H26O8
Molecular Weight562.57
SMILESCC1=CC2C(C3(C4=CC=C(O)C=C4O)OC5=C2C(O)=CC(C6=CC7=C(C=C(O)C=C7)O6)=C5)C(C(C=CC(O)=C8)=C8O3)C1
InChI KeyMJJWBJFYYRAYKU-UHFFFAOYSA-N
Synonymmulberrofuran G;albanol A;Mulberrofuran G((+)-Albanol A,Albanol A);3aH-Benzo[3,4][2]benzopyrano[1,8-bc][1]benzopyran-4,11-diol, 8a-(2,4-dihydroxyphenyl)-1,8a,13b,13c-tetrahydro-6-(6-hydroxy-2-benzofuranyl)-2-methyl-, (3aS,8aS,13bS,13cR)-;Mulberrofuran G, 10 mM in DMSO
CAS No.87085-00-5
PubChem CID102384790

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAVOQ618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAVOQ618 route product structure diagram
    ACAVOQ61887085-00-5
Inquiry

2. ACAVOQ618 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAVOQ618 route product structure diagram
    ACAVOQ61887085-00-5
Inquiry

Comments (0)